PEDIATRICS Vol. 116 No. 6 December 2005, pp. 1569-1573 (doi:10.1542/peds.2005-2448)

This Article Full Text Full Text (PDF) Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Search for Related Content PubMed PubMed Citation

CLINICAL REPORT

Cardiovascular Health Supervision for Individuals Affected by Duchenne or Becker Muscular Dystrophy

Duchenne muscular dystrophy is the most common and severe form of the childhood muscular dystrophies. The disease is typically diagnosed between 3 and 7 years of age and follows a predictable clinical course marked by progressive skeletal muscle weakness with loss of ambulation by 12 years of age. Death occurs in early adulthood secondary to respiratory or cardiac failure. Becker muscular dystrophy is less common and has a milder clinical course but also results in respiratory and cardiac failure. The natural history of the cardiomyopathy in these diseases has not been well established. As a result, patients traditionally present for cardiac evaluation only after clinical symptoms become evident. The purpose of this policy statement is to provide recommendations for optimal cardiovascular evaluation to health care specialists caring for individuals in whom the diagnosis of Duchenne or Becker muscular dystrophy has been confirmed.

Key Words: cardiovascular

Abbreviations: DMD, Duchenne muscular dystrophy • BMD, Becker muscular dystrophy

This article has been cited by other articles:

				D. J. Birnkrant, H. B. Panitch, J. O. Benditt, L. J. Boitano, E. R. Carter, V. A. Cwik, J. D. Finder, S. T. Iannaccone, L. E. Jacobson, G. L. Kohn, et al. American College of Chest Physicians Consensus Statement on the Respiratory and Related Management of Patients With Duchenne Muscular Dystrophy Undergoing Anesthesia or Sedation Chest, December 1, 2007; 132(6): 1977 - 1986. [Abstract] [Full Text] [PDF]

				M. C. Silva, Z. M. A. Meira, J. Gurgel Giannetti, M. M. da Silva, A. F. Oliveira Campos, M. de Melo Barbosa, G. M. S. Filho, R. de Aguiar Ferreira, M. Zatz, and C. E. Rochitte Myocardial Delayed Enhancement by Magnetic Resonance Imaging in Patients With Muscular Dystrophy J. Am. Coll. Cardiol., May 8, 2007; 49(18): 1874 - 1879. [Abstract] [Full Text] [PDF]

				J. Rein Therapeutic Nihilism in Duchenne Cardiomyopathy Pediatrics, May 1, 2006; 117(5): 1864 - 1864. [Full Text] [PDF]

				L. Cripe and L. Markham Therapeutic Nihilism in Duchenne Cardiomyopathy: In Reply Pediatrics, May 1, 2006; 117(5): 1865 - 1865. [Full Text] [PDF]